Trial intelligence / Profile preview

Lescol XL in Newly Diagnosed Coronary Heart Disease (FAITH)

NCT01681199Phase 4Unknown

Sponsor
Beijing An Zhen Hospital
Start
Jul 2012
Primary completion
Apr 2014
Countries
1
01

Overview

A Phase 4 trial of fluvastatin in coronary heart disease (CHD), atherosclerosis, sponsored by Beijing An Zhen Hospital. Status: unknown.

02

Drugs

fluvastatin
03

Conditions

coronary heart disease (CHD)atherosclerosis

Beyond the preview

Go deeper on NCT01681199.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01681199.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call